FDA Inspection 1039807 — Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.
The FDA completed an inspection of Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd. on January 26, 2018 in Jinhua. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 26, 2018
- Fiscal Year
- 2018
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Jinhua (China)